SLNCF — Silence Therapeutics Share News
0.000.00%
- $906.79m
- $714.03m
- £25.38m
- 63
- 11
- 57
- 40
REG - Silence Therapeutics - Update on AIM Delisting
AnnouncementREG - FTSE Russell Silence Therapeutics Serica Energy PLC Pantheon Resources - Silence Therapeutics
AnnouncementREG - Silence Therapeutics - Third Quarter 2021 Financial Results
AnnouncementREG - Silence Therapeutics - Silence to Present at Jefferies London Conference
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - New Key Shareholder
AnnouncementREG - Silence Therapeutics - Result of General Meeting
AnnouncementREG - Silence Therapeutics - Total Voting Rights
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Silence Provides Pipeline Updates at 2021 R&D Day
AnnouncementREG - Silence Therapeutics - Silence and Hansoh Pharma Announce Collaboration
AnnouncementREG - Silence Therapeutics - Proposed Cancellation of Trading on AIM
AnnouncementREG - Silence Therapeutics - Block Listing Return
AnnouncementREG - Silence Therapeutics - Total Voting Rights
AnnouncementREG - Silence Therapeutics - Silence Therapeutics to host R&D day
AnnouncementREG - Silence Therapeutics - Chardan Genetic Medicines Conference Participation
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Holding(s) in Company
AnnouncementREG - Silence Therapeutics - Silence Appoints Senior VP of BD, AM and NPD.
Announcement